Imiquimod 3.75 cream applied daily to treat anogenital warts: Combined results from women in two randomized, placebo-controlled studies

Infectious Diseases in Obstetrics and Gynecology

Volumn 2011, Issue , 2011, Pages

  Baker, David A ^a   Ferris, Daron G ^b   Martens, Mark G ^c   Fife, Kenneth H ^d   Tyring, Stephen K ^e   Edwards, Libby ^f   Nelson, Anita ^g   Ault, Kevin ^h   Trofatter, Kenneth F ⁱ   Liu, Tiepu ^j,k   Levy, Sharon ^j   Wu, Jason ^j  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f Mid Charlotte Dermatology and Research   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

^j Graceway Pharmaceuticals LLC   (United States)

^k MEDICINES COMPANY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; PLACEBO; AMINOQUINOLINE DERIVATIVE; ANTIVIRUS AGENT;

APPLICATION SITE BLEEDING; APPLICATION SITE DISCHARGE; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; ARTICLE; CHILD; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; WART VIRUS; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GYNECOLOGIC DISEASE; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL ANALYSIS; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTIVIRAL AGENTS; CONDYLOMATA ACUMINATA; DATA INTERPRETATION, STATISTICAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MIDDLE AGED; PLACEBOS; TREATMENT OUTCOME;

EID: 80053521377     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2011/806105     Document Type: Article

References (25)

1. Revzina N. V., DiClemente R. J., Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review International Journal of STD and AIDS 2005 16 8 528 537 (Pubitemid 41192302)
2. Herzog T. J., Huh W. K., Einstein M. H., How does public policy impact cervical screening and vaccination strategies? Gynecologic Oncology 2010 119 2 175 180
3. Sexually transmitted diseases treatment guidelines. Human papillomavirus (HPV) infection Morbidity and Mortality Weekly Report 2010 59 RR-12 69 74
4. Koutsky L., Epidemiology of genital human papillomavirus infection The American Journal of Medicine 1997 102 3 8 (Pubitemid 127695953)
5. Dinh T. H., Sternberg M., Dunne E. F., Markowitz L. E., Genital warts among 18- to 59-year olds in the United States, national health and nutrition examination survey, 19992004 Sexually Transmitted Diseases 2008 35 4 357 360 (Pubitemid 351440776)
6. Woodhall S. C., Jit M., Cai C., Ramsey T., Zia S., Crouch S., Birks Y., Newton R., Edmunds W. J., Lacey C. J. N., Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom Sexually Transmitted Diseases 2009 36 8 515 521
7. Pirotta M., Ung L., Stein A., Conway E. L., Mast T. C., Fairley C. K., Garland S., The psychosocial burden of human papillomavirus related disease and screening interventions Sexually Transmitted Infections 2009 85 7 508 513
8. Centers for Disease Control and Prevention, Sexually Transmitted Disease Surveillance, 2008 2009 Atlanta, Ga, USA U.S. Department of Health and Human Services
9. Insinga R. P., Dasbach E. J., Elbasha E. H., Assessing the annual economic burden of preventing and treating anogenital human papillomavirus- related disease in the US: analytic framework and review of the literature PharmacoEconomics 2005 23 11 1107 1122 (Pubitemid 41633402)
10. Mayeaux E. J. Jr., Dunton C., Modern management of external genital warts Journal of Lower Genital Tract Disease 2008 12 3 185 192
11. Gaspari A. A., Mechanism of action and other potential roles of an immune response modifier Cutis 2007 79 supplement 4 36 45
12. Edwards L., Ferenczy A., Eron L., Self-administered topical 5 imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus Archives of Dermatology 1998 134 25 30 (Pubitemid 28087109)
13. Page K. R., Sifakis F., Montes de Oca R., Cronin W. A., Doherty M. C., Federline L., Bur S., Walsh T., Karney W., Milman J., Baruch N., Adelakun A., Dorman S. E., Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study Archives of Internal Medicine 2006 166 17 1863 1870 (Pubitemid 44455169)
14. Gupta A. K., Shear N. H., A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis Drug Safety 2000 22 1 33 62
15. Farup P. G., Compliance with anti-ulcer medication during short term healing phase clinical trials Alimentary Pharmacology and Therapeutics 1992 6 179 186
16. Fife K. H., Ferenczy A., Douglas J. M. Jr., Brown D. R., Smith M., Owens M. L., Beutner K., Poretz D., Reichman R., Sperling M., Spruance S., Treatment of external genital warts in men using 5 imiquimod cream applied three times a week, once daily, twice daily, or three times a day Sexually Transmitted Diseases 2001 28 4 226 231 (Pubitemid 32244954)
17. Gollnick H., Barasso R., Jappe U., Ward K., Eul A., Carey-Yard M., Milde K., Safety and efficacy of imiquimod 5 cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day International Journal of STD and AIDS 2001 12 1 22 28 (Pubitemid 32113007)
18. Trofatter K. F. Jr., Ferenczy A., Fife K. H., Increased frequency of dosing of imiquimod 5 cream in the treatment of external genital warts in women International Journal of Gynecology and Obstetrics 2002 76 2 191 193 (Pubitemid 34113749)
19. Ferris D. G., Baker D., Tyring S., Imiquimod 2.5 and 3.75 applied daily for up to 8 weeks to treat external genital warts July 2010 Montreal, Quebec, Canada HPV 2010 544
20. Hochberg Y., A sharper Bonferroni procedure for multiple tests of significance Biometrika 1988 75 4 800 802
21. Aldara (imiquimod cream, 5) prescribing information April 2009 Bristol, Tenn, USA Graceway Pharmaceuticals, LLC
22. Data on file Bristol, Tenn, USA Graceway Pharmaceuticals, LLC
23. Stockfleth E., Beti H., Orasan R., Grigorian F., Mescheder A., Tawfik H., Thielert C., Topical polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial The British Journal of Dermatology 2008 158 6 1329 1338 (Pubitemid 351692865)
24. Stone K. M., Becker T. M., Hadgu A., Kraus S. J., Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy and electrodesiccation Genitourinary Medicine 1990 66 1 16 19 (Pubitemid 20095882)
25. Sauder D. N., Skinner R. B., Fox T. L., Owens M. L., Topical imiquimod 5 cream as an effective treatment for external genital and perianal warts in different patient populations Sexually Transmitted Diseases 2003 30 2 124 128 (Pubitemid 36184359)